February 3, 2025—Cagent Vascular, Inc. announced the launch of its Serranator SL-Pro percutaneous transluminal angioplasty (PTA) serration ballo
Rigorous, dependable research has always been at the core of the American Heart Association (AHA) mission to be a relentless force for a world of…
Looking at the REVIVED-BCIS2 results, Divaka Perera and C. Michael Gibson discuss the relationship between myocardial viability, PCI, and outcomes.
AHA volunteer expert: Daniel T. Lackland, Dr.P.H., FAHA, is an American Heart Association EPI and Stroke Council member and professor of epidemiology and director of the Division…
The authors investigated the impact of weight-adjusted heparin doses on the incidence of radial artery occlusion in patients undergoing diagnostic transradial catheterization
Kaiser Permanente study finds variations in impact of air pollution from 2018 Mendocino Complex and Camp fires on cardiovascular health.
Elon Musk’s DOGE team examines Medicare and Medicaid Services – WSJ
Call For Applications | ACC 2026 Leadership Forum Chair
another transthyretin stabilizer, has very recently been FDA-approved following positive results in the ATTRibute-CM trial. Vutrisiran, a transthyretin gene silencer, demonstrated efficacy in the HELIOS-B…
INTRODUCTION: Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenic shock. This can cause harm and limit the quality…
1919 Connecticut Avenue, NW Washington, DC 20009 Phone: 202.483.3000 *Room Block Opens June
